H.Res. 279 · 112th Congress
Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 112th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
ChandlerSponsorNo cosponsors.
Declares that the House of Representatives seeks to raise public awareness of the risks associated with anticoagulant medications.
What it does: CRS summary · Introduced in House · May 25, 2011
Declares that the House of Representatives seeks to raise public awareness of the risks associated with anticoagulant medications.
Encourages pharmaceutical manufacturers and health care providers to properly communicate the risk of death associated with such drugs to their patients.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.
Latest action (Jun 3, 2011): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: May 25, 2011
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.